Department of Medical and Surgical Sciences, Endocrinology and Diabetology Unit, I.R.C.C.S Policlinico San Donato, University of Milan, Via Morandi 30, San Donato Milanese (MI), Italy.
J Endocrinol Invest. 2010 Oct;33(9):640-3. doi: 10.1007/BF03346663. Epub 2010 Mar 25.
It is recognized that overt thyroid dysfunction is associated with weight changes, but the influence of a minor alteration of thyroid function remains unclear. This study aimed to further investigate the relationship between obesity and thyroid function and to examine the possible role of insulin resistance on the hypothalamic-pituitary- thyroid axis.
Serum TSH and free T4 (FT4) levels, anthropometric and metabolic parameters were evaluated in 581 obese patients. In all patients TSH values progressively increased according to the severity of obesity and were positively correlated with body mass index (p=0.001, r=0.13) and waist circumference (p=0.02, r=0.11). Patients with insulin resistance showed higher TSH (1.8±1.0 vs 1.6±0.9 μUI/l; p=0.03) and lower FT4 levels (13.8±2.3 vs 15.0±2.2 pmol/l; p<0.001), as compared with patients with normal insulin sensitivity. Moreover, TSH was positively correlated with fasting insulin (p<0.001, r=0.152) and homeostasis model assessment of insulin resistance (HOMA-IR; p<0.001, r=0.148), and negatively correlated with Quantitative Insulin Sensitivity Check Index (QUICKI; p<0.001, r=-0.148); FT4 was negatively associated with fasting insulin (p<0.001, r=-0.287) and HOMA-IR (p<0.001, r=-0.295), and positively associated with QUICKI (p<0.001, r=0.295).
A relationship between thyroid function and overweight/ obesity condition seems to exist, mainly influenced by insulin resistance. Whether variations in TSH and/or thyroid hormones, within a normal range, can influence body weight or whether obesity per se can alter thyroid function cannot be stated so far. Further studies are needed to assess the link between thyroid function and body weight, by considering not only changes in thyroid hormones, but also body fat distribution, obesity duration and low-grade inflammation.
众所周知,显性甲状腺功能障碍与体重变化有关,但甲状腺功能的轻微改变的影响尚不清楚。本研究旨在进一步探讨肥胖与甲状腺功能之间的关系,并研究胰岛素抵抗对下丘脑-垂体-甲状腺轴的可能作用。
在 581 例肥胖患者中评估了血清 TSH 和游离 T4(FT4)水平、人体测量学和代谢参数。所有患者的 TSH 值随肥胖程度的加重而逐渐升高,并与体重指数(p=0.001,r=0.13)和腰围(p=0.02,r=0.11)呈正相关。胰岛素抵抗患者的 TSH 更高(1.8±1.0 比 1.6±0.9 μUI/l;p=0.03),FT4 水平更低(13.8±2.3 比 15.0±2.2 pmol/l;p<0.001),与胰岛素敏感性正常的患者相比。此外,TSH 与空腹胰岛素呈正相关(p<0.001,r=0.152),与稳态模型评估的胰岛素抵抗(HOMA-IR;p<0.001,r=0.148)呈负相关,与定量胰岛素敏感性检查指数(QUICKI;p<0.001,r=-0.148)呈负相关;FT4 与空腹胰岛素(p<0.001,r=-0.287)和 HOMA-IR(p<0.001,r=-0.295)呈负相关,与 QUICKI(p<0.001,r=0.295)呈正相关。
甲状腺功能与超重/肥胖状态之间似乎存在关系,主要受胰岛素抵抗的影响。在正常范围内,TSH 和/或甲状腺激素的变化是否会影响体重,或者肥胖本身是否会改变甲状腺功能,目前尚无法确定。需要进一步研究来评估甲状腺功能与体重之间的联系,不仅要考虑甲状腺激素的变化,还要考虑体脂分布、肥胖持续时间和低度炎症。